Company Performance: Samsung Biologics' financial health, revenue growth, profitability, and earnings reports directly influence its stock price. Strong performance typically leads to higher stock valuations.

Industry Trends: The overall health and growth prospects of the biopharmaceutical industry, including trends in biosimilars and novel drug development, impact investor sentiment towards Samsung Biologics.

Regulatory Environment: Changes in regulations related to drug approval processes, pricing policies, and healthcare reforms in South Korea and globally affect the company's outlook and stock price.

Market Sentiment: General investor confidence, macroeconomic conditions, and risk appetite in the South Korean stock market (KOSPI) affect demand for Samsung Biologics' shares.

Competition: The competitive landscape, including the emergence of new players and the actions of existing rivals, influences Samsung Biologics' market share and profitability, impacting its stock value.

Global Economy: Economic conditions in major markets, such as the US and Europe, which affect pharmaceutical demand and investment flows, can also play a role.

Specific News: Company-specific news, such as announcements of new contracts, clinical trial results, or regulatory approvals, can trigger significant price movements.

Interest Rates: Changes in interest rates can affect the cost of capital for Samsung Biologics and influence its investment decisions, potentially affecting its stock price.

Currency Exchange Rates: Fluctuations in the value of the Korean Won (KRW) against other currencies can impact the company's revenues and profitability, especially its export business.

Investor Relations: How well Samsung Biologics manages its investor relations and communicates its strategy can impact investor confidence and stock valuation.